XLO
Xilio Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$9.13
+1.00%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 3.83x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.83x
- Price / sales
- 0.94x
- Price / cash flow
- -0.99x
Enterprise value
- Enterprise value
- -$69.7M
- EV / sales
- -1.09x
- EV / EBITDA
- 3.40x
- EV / EBIT
- 2.22x
- Market cap
- $60.1M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026